Yee V C, Pedersen L C, Bishop P D, Stenkamp R E, Teller D C
Department of Biochemistry, University of Washington, Seattle 98195, USA.
Thromb Res. 1995 Jun 1;78(5):389-97. doi: 10.1016/0049-3848(95)00072-y.
The three-dimensional structure of the recombinant human factor XIII a2 dimer after cleavage by thrombin has been determined by X-ray crystallography. Factor XIII zymogen was treated with bovine alpha-thrombin in the presence of 3 mM CaCl2, and the cleaved protein was crystallized from Tris buffered at pH 6.5 using ethanol as the precipitating agent. Refinement of the molecular model of thrombin-cleaved factor XIII against diffraction data from 10.0 to 2.5 A resolution has been carried out to give a crystallographic R factor of 18.2%. The structure of thrombin-cleaved factor XIII is remarkably similar to that of the zymogen: there are no large conformational changes in the protein and the 37 residue amino terminus activation peptide remains associated with the rest of the molecule. This work shows that the activation peptide, upon thrombin cleavage, has the same conformation and occupies the same position with respect to the rest of the molecule as it does in the zymogen structure.
已通过X射线晶体学确定了凝血酶切割后重组人因子XIII a2二聚体的三维结构。在3 mM氯化钙存在的情况下,因子XIII酶原用牛α-凝血酶处理,然后使用乙醇作为沉淀剂,从pH 6.5的Tris缓冲液中使切割后的蛋白质结晶。针对分辨率为10.0至2.5 Å的衍射数据对凝血酶切割的因子XIII分子模型进行了精修,得到的晶体学R因子为18.2%。凝血酶切割的因子XIII的结构与酶原的结构非常相似:蛋白质中没有大的构象变化,37个残基的氨基末端激活肽仍与分子的其余部分相连。这项工作表明,激活肽在被凝血酶切割后,具有与酶原结构中相同的构象,并且相对于分子的其余部分占据相同的位置。